{"id":27024,"date":"2026-07-06T07:53:49","date_gmt":"2026-07-06T07:53:49","guid":{"rendered":"https:\/\/www.legalserviceindia.com\/Legal-Articles\/?p=27024"},"modified":"2026-07-06T07:55:58","modified_gmt":"2026-07-06T07:55:58","slug":"milmet-oftho-industries-v-allergan-inc-supreme-court-on-trans-border-reputation-pharmaceutical-trademarks","status":"publish","type":"post","link":"https:\/\/www.legalserviceindia.com\/Legal-Articles\/milmet-oftho-industries-v-allergan-inc-supreme-court-on-trans-border-reputation-pharmaceutical-trademarks\/","title":{"rendered":"Milmet Oftho Industries v. Allergan Inc.: Supreme Court on Trans-Border Reputation &amp; Pharmaceutical Trademarks"},"content":{"rendered":"\n<h2 id=\"h-introduction\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Introduction\"><\/span>Introduction<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The decision of the Supreme Court in <strong>Milmet Oftho Industries &amp; Ors v. Allergan Inc.<\/strong> is one of the most significant judgements in Indian trademark jurisprudence concerning pharmaceutical products, trans-border reputation, and passing-off actions involving multinational corporations and Indian companies. The case addressed a recurring issue in an increasingly globalised marketplace: whether a foreign pharmaceutical company that has established a reputation and prior use of a trademark internationally can restrain an Indian company from using the same mark in India, even when the foreign company has not yet commenced actual sales in the Indian market.<\/p><div id=\"ez-toc-container\" class=\"ez-toc-v2_0_85 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #0c0c0c;color:#0c0c0c\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #0c0c0c;color:#0c0c0c\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/www.legalserviceindia.com\/Legal-Articles\/milmet-oftho-industries-v-allergan-inc-supreme-court-on-trans-border-reputation-pharmaceutical-trademarks\/#Introduction\" >Introduction<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/www.legalserviceindia.com\/Legal-Articles\/milmet-oftho-industries-v-allergan-inc-supreme-court-on-trans-border-reputation-pharmaceutical-trademarks\/#Key_Highlights_of_the_Judgment\" >Key Highlights of the Judgment<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/www.legalserviceindia.com\/Legal-Articles\/milmet-oftho-industries-v-allergan-inc-supreme-court-on-trans-border-reputation-pharmaceutical-trademarks\/#Factual_and_Procedural_Background\" >Factual and Procedural Background<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/www.legalserviceindia.com\/Legal-Articles\/milmet-oftho-industries-v-allergan-inc-supreme-court-on-trans-border-reputation-pharmaceutical-trademarks\/#Background_at_a_Glance\" >Background at a Glance<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/www.legalserviceindia.com\/Legal-Articles\/milmet-oftho-industries-v-allergan-inc-supreme-court-on-trans-border-reputation-pharmaceutical-trademarks\/#Dispute_Before_the_Court\" >Dispute Before the Court<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/www.legalserviceindia.com\/Legal-Articles\/milmet-oftho-industries-v-allergan-inc-supreme-court-on-trans-border-reputation-pharmaceutical-trademarks\/#Principal_Issues_Before_the_Supreme_Court\" >Principal Issues Before the Supreme Court<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/www.legalserviceindia.com\/Legal-Articles\/milmet-oftho-industries-v-allergan-inc-supreme-court-on-trans-border-reputation-pharmaceutical-trademarks\/#Reasoning_and_Analysis_of_the_Court\" >Reasoning and Analysis of the Court<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/www.legalserviceindia.com\/Legal-Articles\/milmet-oftho-industries-v-allergan-inc-supreme-court-on-trans-border-reputation-pharmaceutical-trademarks\/#Precedents_Relied_Upon_by_the_Court\" >Precedents Relied Upon by the Court<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/www.legalserviceindia.com\/Legal-Articles\/milmet-oftho-industries-v-allergan-inc-supreme-court-on-trans-border-reputation-pharmaceutical-trademarks\/#Higher_Standard_for_Pharmaceutical_Trademarks\" >Higher Standard for Pharmaceutical Trademarks<\/a><ul class='ez-toc-list-level-4' ><li class='ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/www.legalserviceindia.com\/Legal-Articles\/milmet-oftho-industries-v-allergan-inc-supreme-court-on-trans-border-reputation-pharmaceutical-trademarks\/#Why_Pharmaceutical_Trademarks_Require_Stricter_Protection\" >Why Pharmaceutical Trademarks Require Stricter Protection<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/www.legalserviceindia.com\/Legal-Articles\/milmet-oftho-industries-v-allergan-inc-supreme-court-on-trans-border-reputation-pharmaceutical-trademarks\/#International_Character_of_the_Pharmaceutical_Industry\" >International Character of the Pharmaceutical Industry<\/a><ul class='ez-toc-list-level-4' ><li class='ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/www.legalserviceindia.com\/Legal-Articles\/milmet-oftho-industries-v-allergan-inc-supreme-court-on-trans-border-reputation-pharmaceutical-trademarks\/#Factors_Considered_by_the_Court\" >Factors Considered by the Court<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/www.legalserviceindia.com\/Legal-Articles\/milmet-oftho-industries-v-allergan-inc-supreme-court-on-trans-border-reputation-pharmaceutical-trademarks\/#Important_Qualification_Laid_Down_by_the_Supreme_Court\" >Important Qualification Laid Down by the Supreme Court<\/a><ul class='ez-toc-list-level-4' ><li class='ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/www.legalserviceindia.com\/Legal-Articles\/milmet-oftho-industries-v-allergan-inc-supreme-court-on-trans-border-reputation-pharmaceutical-trademarks\/#Balance_Maintained_by_the_Court\" >Balance Maintained by the Court<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/www.legalserviceindia.com\/Legal-Articles\/milmet-oftho-industries-v-allergan-inc-supreme-court-on-trans-border-reputation-pharmaceutical-trademarks\/#Application_of_Law_to_the_Facts\" >Application of Law to the Facts<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/www.legalserviceindia.com\/Legal-Articles\/milmet-oftho-industries-v-allergan-inc-supreme-court-on-trans-border-reputation-pharmaceutical-trademarks\/#Court_Analysis_at_a_Glance\" >Court Analysis at a Glance<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/www.legalserviceindia.com\/Legal-Articles\/milmet-oftho-industries-v-allergan-inc-supreme-court-on-trans-border-reputation-pharmaceutical-trademarks\/#Final_Decision_of_the_Court\" >Final Decision of the Court<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/www.legalserviceindia.com\/Legal-Articles\/milmet-oftho-industries-v-allergan-inc-supreme-court-on-trans-border-reputation-pharmaceutical-trademarks\/#Supreme_Court_Directions\" >Supreme Court Directions<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/www.legalserviceindia.com\/Legal-Articles\/milmet-oftho-industries-v-allergan-inc-supreme-court-on-trans-border-reputation-pharmaceutical-trademarks\/#Point_of_Law_Settled\" >Point of Law Settled<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/www.legalserviceindia.com\/Legal-Articles\/milmet-oftho-industries-v-allergan-inc-supreme-court-on-trans-border-reputation-pharmaceutical-trademarks\/#Legal_Principles_Established\" >Legal Principles Established<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/www.legalserviceindia.com\/Legal-Articles\/milmet-oftho-industries-v-allergan-inc-supreme-court-on-trans-border-reputation-pharmaceutical-trademarks\/#Key_Takeaways\" >Key Takeaways<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/www.legalserviceindia.com\/Legal-Articles\/milmet-oftho-industries-v-allergan-inc-supreme-court-on-trans-border-reputation-pharmaceutical-trademarks\/#Case_Details\" >Case Details<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/www.legalserviceindia.com\/Legal-Articles\/milmet-oftho-industries-v-allergan-inc-supreme-court-on-trans-border-reputation-pharmaceutical-trademarks\/#Conclusion\" >Conclusion<\/a><\/li><\/ul><\/nav><\/div>\n\n\n\n\n<p class=\"wp-block-paragraph\">The judgement is particularly important because it balances two competing interests. On one hand, it recognises the growing importance of international reputation and global goodwill in pharmaceutical trademarks. On the other hand, it cautions that multinational corporations should not be permitted to block Indian enterprises merely by claiming worldwide use of a mark without any genuine intention of entering the Indian market.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The decision continues to be a leading authority on trans-border reputation, passing off, pharmaceutical trademarks, and the principle that the ultimate inquiry in such disputes is often to determine who was first in the market.<\/p>\n\n\n\n<h3 id=\"h-key-highlights-of-the-judgment\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Key_Highlights_of_the_Judgment\"><\/span>Key Highlights of the Judgment<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Aspect<\/th><th>Details<\/th><\/tr><\/thead><tbody><tr><td>Primary Issue<\/td><td>Protection of internationally reputed pharmaceutical trademarks in India.<\/td><\/tr><tr><td>Core Legal Principle<\/td><td>Recognition of trans-border reputation and prior international use.<\/td><\/tr><tr><td>Area of Law<\/td><td>Trademark Law, Passing Off, Pharmaceutical Trademarks.<\/td><\/tr><tr><td>Significance<\/td><td>Clarifies the balance between multinational trademark rights and legitimate Indian business interests.<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 id=\"h-factual-and-procedural-background\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Factual_and_Procedural_Background\"><\/span>Factual and Procedural Background<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The dispute arose between Milmet Oftho Industries and others, a Indian pharmaceutical company, and Allergan Inc., a multinational pharmaceutical corporation engaged in the manufacture and sale of pharmaceutical products across several countries.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The controversy concerned the trademark <strong>&#8220;OCUFLOX&#8221;,<\/strong> which was used in relation to medicinal products intended for eye care and ophthalmic treatment. Allergan claimed that it had adopted and first used the mark \u201cOCUFLOX\u201d on 9 September 1992 in connection with an ophthalmic preparation containing ofloxacin and related compounds. According to Allergan, the product had thereafter been marketed in various countries, including Europe, Australia, South Africa, South America, Canada, Mexico, Peru, Bolivia, Ecuador, and the United States. Allergan had also secured trademark registrations in several jurisdictions and had filed applications for registration in India and other countries.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Milmet Oftho Industries, meanwhile, was marketing a medicinal product under the identical mark &#8220;OCUFLOX&#8221;. The Indian company contended that it had independently coined the mark by combining the prefix \u201cOCU\u201d derived from the word \u201cocular\u201d and \u201cFLOX\u201d derived from &#8220;Ciprofloxacin&#8221;, which was a principal ingredient of its product. The company had obtained permission from the Food and Drug Control Administration on 25 August 1993 and had also applied for registration of the mark in September 1993.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Allergan instituted a passing-off action seeking an injunction against the use of the mark by the Indian company. An ad interim injunction was initially granted on 18 December 1996. However, the Single Judge later vacated the injunction on 29 January 1997, holding that Allergan&#8217;s product was not being sold in India and that Milmet had introduced its product in the Indian market earlier.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Allergan challenged the order before the Division Bench of the Calcutta High Court. The Division Bench reversed the Single Judge\u2019s decision and held that Allergan was the first in the market and therefore entitled to protection. Aggrieved by this decision, Milmet Oftho Industries approached the Supreme Court by way of appeal.<\/p>\n\n\n\n<h3 id=\"h-background-at-a-glance\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Background_at_a_Glance\"><\/span>Background at a Glance<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Particular<\/th><th>Details<\/th><\/tr><\/thead><tbody><tr><td>Plaintiff<\/td><td>Allergan Inc.<\/td><\/tr><tr><td>Defendant<\/td><td>Milmet Oftho Industries &amp; Others<\/td><\/tr><tr><td>Trademark in Dispute<\/td><td>OCUFLOX<\/td><\/tr><tr><td>Nature of Product<\/td><td>Ophthalmic pharmaceutical preparation<\/td><\/tr><tr><td>Main Legal Remedy Sought<\/td><td>Passing-off injunction<\/td><\/tr><tr><td>Issue Before Supreme Court<\/td><td>Whether prior international use without actual sales in India could restrain use by an Indian company.<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 id=\"h-dispute-before-the-court\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Dispute_Before_the_Court\"><\/span>Dispute Before the Court<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The principal question before the Supreme Court was whether a foreign pharmaceutical company that had adopted and used a trademark internationally before an Indian company could restrain the Indian company from using the same mark in India, even though the foreign company had not yet commenced actual sales of the product in India.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The case also required the Court to examine the principles governing passing-off actions involving medicinal products, the relevance of transborder reputation, and the extent to which international use and advertising could confer rights enforceable in India.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Allergan argued that it was the prior adopter and prior user of the mark \u201cOCUFLOX\u201d globally and had established goodwill and reputation across multiple jurisdictions. It contended that permitting the Indian company to use the identical mark would create confusion in the pharmaceutical market and damage its reputation.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Milmet Oftho Industries contended that it had independently developed the mark, had obtained regulatory approvals in India, and was the first company to market products under the mark within India. It argued that a company not trading in India should not be entitled to restrain a domestic enterprise from carrying on legitimate business activities.<\/p>\n\n\n\n<h3 id=\"h-principal-issues-before-the-supreme-court\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Principal_Issues_Before_the_Supreme_Court\"><\/span>Principal Issues Before the Supreme Court<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Whether prior international adoption and use of a pharmaceutical trademark can prevail over subsequent use in India.<\/li>\n\n\n\n<li>Whether a foreign company without actual sales in India can maintain a passing-off action.<\/li>\n\n\n\n<li>Whether trans-border reputation is sufficient to obtain protection under Indian trademark law.<\/li>\n\n\n\n<li>How courts should balance multinational trademark rights with legitimate Indian commercial interests.<\/li>\n\n\n\n<li>Whether public interest and consumer safety require stricter scrutiny in pharmaceutical trademark disputes.<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 id=\"h-reasoning-and-analysis-of-the-court\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Reasoning_and_Analysis_of_the_Court\"><\/span>Reasoning and Analysis of the Court<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The Supreme Court began by examining the settled principles governing passing-off actions. The Court referred extensively to the landmark decision in <strong>N.R. Dongre v. Whirlpool Corporation, MANU\/SC\/0395\/1996<\/strong>, which recognised the doctrine of trans-border reputation and held that a passing-off action can be maintained even against a registered proprietor where the plaintiff enjoys superior goodwill and reputation. The court noted that in Whirlpool, the mark had acquired substantial international recognition, and its reputation extended into India despite limited commercial activity within the country.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The Court also relied upon <strong>Cadila Health Care Ltd v. Cadila Pharmaceuticals Ltd, 2001 PTC 300 (SC)<\/strong>, a leading decision concerning deceptive similarity in pharmaceutical trademarks. The court reiterated the factors laid down in Cadila for assessing deceptive similarity, including the nature of the marks, degree of resemblance, nature of goods, similarity in character and performance, class of purchasers, mode of purchase, and surrounding circumstances.<\/p>\n\n\n\n<h3 id=\"h-precedents-relied-upon-by-the-court\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Precedents_Relied_Upon_by_the_Court\"><\/span>Precedents Relied Upon by the Court<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Case<\/th><th>Legal Principle Applied<\/th><\/tr><\/thead><tbody><tr><td><strong>N.R. Dongre v. Whirlpool Corporation<\/strong><\/td><td>Recognition of trans-border reputation and protection through passing-off even against a registered proprietor.<\/td><\/tr><tr><td><strong>Cadila Health Care Ltd. v. Cadila Pharmaceuticals Ltd.<\/strong><\/td><td>Tests for determining deceptive similarity in pharmaceutical trademarks.<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 id=\"h-higher-standard-for-pharmaceutical-trademarks\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Higher_Standard_for_Pharmaceutical_Trademarks\"><\/span>Higher Standard for Pharmaceutical Trademarks<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">The court emphasised that medicinal products require a much higher degree of judicial scrutiny than ordinary consumer goods. Confusion in pharmaceutical products can have serious consequences affecting public health and patient safety. The Court noted that mistakes can occur even among trained medical professionals and pharmacists, particularly because prescriptions are often handwritten or communicated telephonically. Consequently, courts must adopt a stricter approach when evaluating similarity between pharmaceutical marks.<\/p>\n\n\n\n<h4 id=\"h-why-pharmaceutical-trademarks-require-stricter-protection\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Why_Pharmaceutical_Trademarks_Require_Stricter_Protection\"><\/span>Why Pharmaceutical Trademarks Require Stricter Protection<span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Medicinal products directly affect public health.<\/li>\n\n\n\n<li>Confusion between similar drug names may endanger patients.<\/li>\n\n\n\n<li>Doctors&#8217; prescriptions may be handwritten or communicated verbally.<\/li>\n\n\n\n<li>Dispensing errors may occur even among trained professionals.<\/li>\n\n\n\n<li>Consumer safety must take precedence over commercial considerations.<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 id=\"h-international-character-of-the-pharmaceutical-industry\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"International_Character_of_the_Pharmaceutical_Industry\"><\/span>International Character of the Pharmaceutical Industry<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">While discussing modern commercial realities, the Court observed that the pharmaceutical industry had acquired a distinctly international character. Medical professionals routinely access international medical literature, attend global conferences, and remain informed about developments in pharmaceutical products worldwide. The widespread availability of advertising and medical information enables pharmaceutical products to acquire a reputation across national borders. Therefore, a mark associated with a particular drug internationally may already enjoy recognition among medical professionals and consumers in India even before the product is physically introduced into the country.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The Court held that permitting identical marks for similar pharmaceutical products could create confusion and potentially endanger public interest. Consequently, courts must consider not merely domestic sales but also international reputation and prior adoption.<\/p>\n\n\n\n<h4 id=\"h-factors-considered-by-the-court\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Factors_Considered_by_the_Court\"><\/span>Factors Considered by the Court<span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li>International goodwill and reputation.<\/li>\n\n\n\n<li>Prior adoption of the trademark.<\/li>\n\n\n\n<li>Advertising and promotional activities across jurisdictions.<\/li>\n\n\n\n<li>Recognition among medical professionals.<\/li>\n\n\n\n<li>Likelihood of consumer confusion.<\/li>\n\n\n\n<li>Public health implications.<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 id=\"h-important-qualification-laid-down-by-the-supreme-court\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Important_Qualification_Laid_Down_by_the_Supreme_Court\"><\/span>Important Qualification Laid Down by the Supreme Court<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">However, the Supreme Court introduced an important qualification. It cautioned that multinational corporations should not be allowed to monopolise marks in India merely on the basis of foreign reputation if they have no genuine intention of entering the Indian market. Such an approach could unfairly suppress Indian enterprises that have honestly adopted a mark and developed their products independently. The Court therefore stated that the ultimate test should be determining who was first in the market.<\/p>\n\n\n\n<h4 id=\"h-balance-maintained-by-the-court\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Balance_Maintained_by_the_Court\"><\/span>Balance Maintained by the Court<span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Protection Granted<\/th><th>Limitation Imposed<\/th><\/tr><\/thead><tbody><tr><td>Recognition of international reputation and goodwill.<\/td><td>Foreign companies cannot indefinitely block Indian businesses without genuine intention to enter India.<\/td><\/tr><tr><td>Protection against passing off based on trans-border reputation.<\/td><td>The ultimate inquiry remains who was first in the market.<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 id=\"h-application-of-law-to-the-facts\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Application_of_Law_to_the_Facts\"><\/span>Application of Law to the Facts<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Applying these principles to the facts, the Court noted that the Division Bench had relied upon material indicating that Allergan&#8217;s product had been advertised and promoted before Milmet entered the field. This material prima facie suggested that Allergan was the first adopter and user of the mark. Therefore, the Division Bench\u2019s conclusion granting protection to Allergan could not be faulted at the interlocutory stage.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">At the same time, the court recognised that the appellants disputed Allergan&#8217;s claim of prior adoption and argued that the evidence was insufficient to establish first use. Since these issues required a detailed examination of evidence, the Court concluded that they should be decided during trial rather than at the interim stage.<\/p>\n\n\n\n<h3 id=\"h-court-analysis-at-a-glance\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Court_Analysis_at_a_Glance\"><\/span>Court Analysis at a Glance<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Issue<\/th><th>Court&#8217;s View<\/th><\/tr><\/thead><tbody><tr><td>Trans-border reputation<\/td><td>Recognised and legally enforceable in appropriate cases.<\/td><\/tr><tr><td>Pharmaceutical trademarks<\/td><td>Require stricter judicial scrutiny due to public health concerns.<\/td><\/tr><tr><td>International advertising<\/td><td>May establish goodwill extending into India.<\/td><\/tr><tr><td>Foreign companies<\/td><td>Must demonstrate genuine intention of entering the Indian market.<\/td><\/tr><tr><td>Interim injunction<\/td><td>Proper to continue until disputed evidence is fully examined during trial.<\/td><\/tr><tr><td>Ultimate test<\/td><td>Determine who was first in the market.<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 id=\"h-final-decision-of-the-court\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Final_Decision_of_the_Court\"><\/span>Final Decision of the Court<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The Supreme Court declined to interfere with the injunction operating against Milmet Oftho Industries and directed that the injunction should continue pending final adjudication of the suit.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The Court observed that the appellants had already been marketing their product under an alternative name because of the injunction and that the balance of convenience favoured maintaining the existing arrangement until the evidence was fully examined. The Court clarified that if Allergan ultimately proved prior adoption and prior use of the mark, it would be entitled to permanent protection. Conversely, if the evidence established that Allergan had not adopted the mark prior to its use by the Indian company, the trial court would be free to vacate the injunction and assess damages suffered by the appellants.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The appeal was disposed of without costs. The Supreme Court further directed that the suit be expedited and requested the trial court to dispose of it as early as possible, preferably within six months.<\/p>\n\n\n\n<h3 id=\"h-supreme-court-directions\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Supreme_Court_Directions\"><\/span>Supreme Court Directions<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>The interim injunction in favour of Allergan was allowed to continue.<\/li>\n\n\n\n<li>The disputed issues relating to prior adoption and prior use were left to be decided after recording evidence during trial.<\/li>\n\n\n\n<li>The balance of convenience favoured maintaining the existing position.<\/li>\n\n\n\n<li>The trial court was requested to dispose of the suit expeditiously, preferably within six months.<\/li>\n\n\n\n<li>The appeal was disposed of without any order as to costs.<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 id=\"h-point-of-law-settled\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Point_of_Law_Settled\"><\/span>Point of Law Settled<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The judgment establishes and clarifies several important principles of trademark law.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">First, in cases involving pharmaceutical products, courts must apply a stricter standard when assessing deceptive similarity because confusion may adversely affect public health and safety.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Second, trans-border reputation is a legally recognized concept in India. A foreign company may obtain protection against passing off even if its products are not yet physically sold in India, provided it can establish prior adoption, reputation, and goodwill extending into the Indian market.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Third, the Court recognized that globalization and the international flow of information have transformed the assessment of trademark reputation, particularly in the pharmaceutical sector.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Most importantly, the judgment introduced a significant caveat that multinational corporations should not be permitted to prevent Indian companies from using a mark where the foreign company has no genuine intention of entering the Indian market. The Court emphasized that the ultimate test in such disputes is to determine who is truly first in the market.<\/p>\n\n\n\n<h3 id=\"h-legal-principles-established\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Legal_Principles_Established\"><\/span>Legal Principles Established<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Principle<\/th><th>Position Settled by the Supreme Court<\/th><\/tr><\/thead><tbody><tr><td>Pharmaceutical Trademarks<\/td><td>Require a higher degree of protection because confusion may affect public health.<\/td><\/tr><tr><td>Trans-Border Reputation<\/td><td>Recognized as enforceable under Indian trademark law even before actual sales in India.<\/td><\/tr><tr><td>Passing-Off<\/td><td>Available to a foreign proprietor possessing superior goodwill and reputation.<\/td><\/tr><tr><td>International Reputation<\/td><td>Advertising and global recognition may create protectable goodwill in India.<\/td><\/tr><tr><td>Rights of Indian Enterprises<\/td><td>Foreign companies cannot monopolize marks without a genuine intention of entering the Indian market.<\/td><\/tr><tr><td>Ultimate Test<\/td><td>The decisive inquiry is to determine who was first in the market.<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 id=\"h-key-takeaways\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Key_Takeaways\"><\/span>Key Takeaways<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>The judgment is a landmark authority on trans-border reputation in India.<\/li>\n\n\n\n<li>International goodwill can receive protection through a passing-off action.<\/li>\n\n\n\n<li>Public health considerations demand stricter scrutiny of pharmaceutical trademarks.<\/li>\n\n\n\n<li>Prior international use is an important factor, but it is not absolute.<\/li>\n\n\n\n<li>Foreign companies must demonstrate a genuine intention to enter the Indian market.<\/li>\n\n\n\n<li>The determining factor remains identifying who was first in the market.<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 id=\"h-case-details\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Case_Details\"><\/span>Case Details<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><th>Title of the Case<\/th><td>Milmet Oftho Industries &amp; Ors. Vs. Allergan Inc.<\/td><\/tr><tr><th>Date of Judgment\/Order<\/th><td>07 May 2004<\/td><\/tr><tr><th>Case Number<\/th><td>Civil Appeal No. 5791 of 1998<\/td><\/tr><tr><th>Citations<\/th><td>(2004) 12 SCC 624<\/td><\/tr><tr><th>Name of Court<\/th><td>Supreme Court of India<\/td><\/tr><tr><th>Name of Hon&#8217;ble Judge<\/th><td>Justice S.N. Variava and Justice H.K. Sema<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 id=\"h-conclusion\" class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span>Conclusion<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The decision in <strong>Milmet Oftho Industries &amp; Ors. Vs. Allergan Inc.<\/strong> remains one of the foundational judgments governing trans-border reputation, passing-off actions, and pharmaceutical trademarks in India. It reaffirmed that international goodwill can receive legal protection while simultaneously ensuring that multinational corporations do not unfairly prevent Indian enterprises from honestly conducting business without a genuine intention to enter the Indian market. By emphasizing public health, consumer protection, and the importance of determining who was first in the market, the Supreme Court laid down principles that continue to guide trademark disputes involving pharmaceutical products and internationally reputed marks.<\/p>\n\n\n\n<ul class=\"wp-block-yoast-seo-related-links yoast-seo-related-links\">\n<li><a href=\"https:\/\/www.legalserviceindia.com\/Legal-Articles\/tratransborder-reputation-under-indian-trademark-law\/\">Transborder Reputation under Indian Trademark Law<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.legalserviceindia.com\/Legal-Articles\/evaluating-trans-border-reputation-and-bad-faith-adoption-in-indian-trademark-law\/\">Evaluating Trans-Border Reputation and Bad Faith Adoption in Indian Trademark Law<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.legalserviceindia.com\/Legal-Articles\/brand-battles-recent-trends-in-trademark-and-trade-dress-infringement\/\">Brand Battles: Recent Trends in Trademark and Trade Dress Infringement<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.legalserviceindia.com\/Legal-Articles\/balancing-intellectual-property-rights-and-access-to-medicine\/\">Balancing Intellectual Property Rights And Access To Medicine<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.legalserviceindia.com\/Legal-Articles\/role-of-transborder-reputation-in-trademark-rectification\/\">Role of transborder reputation in Trademark Rectification<\/a><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Introduction The decision of the Supreme Court in Milmet Oftho Industries &amp; Ors v. Allergan Inc. is one of the most significant judgements in Indian trademark jurisprudence concerning pharmaceutical products, trans-border reputation, and passing-off actions involving multinational corporations and Indian companies. The case addressed a recurring issue in an increasingly globalised marketplace: whether a foreign<\/p>\n","protected":false},"author":56,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"two_page_speed":[],"_jetpack_memberships_contains_paid_content":false,"_joinchat":[],"footnotes":""},"categories":[21],"tags":[5149],"class_list":["post-27024","post","type-post","status-publish","format-standard","category-intellectual-property","tag-intellectual-property"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.9 (Yoast SEO v27.9) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Milmet Oftho Industries v. Allergan Inc.: Supreme Court on Trans-Border Reputation &amp; Pharmaceutical Trademarks - Legal Service India - Articles<\/title>\n<meta name=\"description\" content=\"Explore the Milmet v. Allergan Supreme Court ruling on transborder reputation, pharmaceutical trademarks, passing off, and prior user rights.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.legalserviceindia.com\/Legal-Articles\/milmet-oftho-industries-v-allergan-inc-supreme-court-on-trans-border-reputation-pharmaceutical-trademarks\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Milmet Oftho Industries v. Allergan Inc.: Supreme Court on Trans-Border Reputation &amp; Pharmaceutical Trademarks\" \/>\n<meta property=\"og:description\" content=\"Explore the Milmet v. Allergan Supreme Court ruling on transborder reputation, pharmaceutical trademarks, passing off, and prior user rights.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.legalserviceindia.com\/Legal-Articles\/milmet-oftho-industries-v-allergan-inc-supreme-court-on-trans-border-reputation-pharmaceutical-trademarks\/\" \/>\n<meta property=\"og:site_name\" content=\"Legal Service India - Articles\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/legalservicesind\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-06T07:53:49+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-06T07:55:58+00:00\" \/>\n<meta name=\"author\" content=\"ADVOCATE AJAY AMITABH SUMAN\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@legalserviceind\" \/>\n<meta name=\"twitter:site\" content=\"@legalserviceind\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"ADVOCATE AJAY AMITABH SUMAN\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"11 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.legalserviceindia.com\\\/Legal-Articles\\\/milmet-oftho-industries-v-allergan-inc-supreme-court-on-trans-border-reputation-pharmaceutical-trademarks\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.legalserviceindia.com\\\/Legal-Articles\\\/milmet-oftho-industries-v-allergan-inc-supreme-court-on-trans-border-reputation-pharmaceutical-trademarks\\\/\"},\"author\":{\"name\":\"ADVOCATE AJAY AMITABH SUMAN\",\"@id\":\"https:\\\/\\\/www.legalserviceindia.com\\\/Legal-Articles\\\/#\\\/schema\\\/person\\\/96ae33c2330691e5b3ccd88cf127a305\"},\"headline\":\"Milmet Oftho Industries v. Allergan Inc.: Supreme Court on Trans-Border Reputation &amp; Pharmaceutical Trademarks\",\"datePublished\":\"2026-07-06T07:53:49+00:00\",\"dateModified\":\"2026-07-06T07:55:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.legalserviceindia.com\\\/Legal-Articles\\\/milmet-oftho-industries-v-allergan-inc-supreme-court-on-trans-border-reputation-pharmaceutical-trademarks\\\/\"},\"wordCount\":2432,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.legalserviceindia.com\\\/Legal-Articles\\\/#organization\"},\"keywords\":[\"Intellectual Property\"],\"articleSection\":[\"Intellectual Property\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.legalserviceindia.com\\\/Legal-Articles\\\/milmet-oftho-industries-v-allergan-inc-supreme-court-on-trans-border-reputation-pharmaceutical-trademarks\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.legalserviceindia.com\\\/Legal-Articles\\\/milmet-oftho-industries-v-allergan-inc-supreme-court-on-trans-border-reputation-pharmaceutical-trademarks\\\/\",\"url\":\"https:\\\/\\\/www.legalserviceindia.com\\\/Legal-Articles\\\/milmet-oftho-industries-v-allergan-inc-supreme-court-on-trans-border-reputation-pharmaceutical-trademarks\\\/\",\"name\":\"Milmet Oftho Industries v. Allergan Inc.: Supreme Court on Trans-Border Reputation &amp; Pharmaceutical Trademarks - Legal Service India - Articles\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.legalserviceindia.com\\\/Legal-Articles\\\/#website\"},\"datePublished\":\"2026-07-06T07:53:49+00:00\",\"dateModified\":\"2026-07-06T07:55:58+00:00\",\"description\":\"Explore the Milmet v. Allergan Supreme Court ruling on transborder reputation, pharmaceutical trademarks, passing off, and prior user rights.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.legalserviceindia.com\\\/Legal-Articles\\\/milmet-oftho-industries-v-allergan-inc-supreme-court-on-trans-border-reputation-pharmaceutical-trademarks\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.legalserviceindia.com\\\/Legal-Articles\\\/milmet-oftho-industries-v-allergan-inc-supreme-court-on-trans-border-reputation-pharmaceutical-trademarks\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.legalserviceindia.com\\\/Legal-Articles\\\/milmet-oftho-industries-v-allergan-inc-supreme-court-on-trans-border-reputation-pharmaceutical-trademarks\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.legalserviceindia.com\\\/Legal-Articles\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Intellectual Property > Milmet Oftho Industries v. Allergan Inc.: Supreme Court on Trans-Border Reputation & Pharmaceutical Trademarks\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.legalserviceindia.com\\\/Legal-Articles\\\/#website\",\"url\":\"https:\\\/\\\/www.legalserviceindia.com\\\/Legal-Articles\\\/\",\"name\":\"Legal Service India - Law Articles\",\"description\":\"Legal Service India - Law Article Directory is the oldest in India since 2000, with thousands of article written by lawyers, law Students and Scholars on all branches of law\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.legalserviceindia.com\\\/Legal-Articles\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.legalserviceindia.com\\\/Legal-Articles\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.legalserviceindia.com\\\/Legal-Articles\\\/#organization\",\"name\":\"Legal Service India\",\"url\":\"https:\\\/\\\/www.legalserviceindia.com\\\/Legal-Articles\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.legalserviceindia.com\\\/Legal-Articles\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.legalserviceindia.com\\\/Legal-Articles\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/logo-circle-1.png\",\"contentUrl\":\"https:\\\/\\\/www.legalserviceindia.com\\\/Legal-Articles\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/logo-circle-1.png\",\"width\":105,\"height\":95,\"caption\":\"Legal Service India\"},\"image\":{\"@id\":\"https:\\\/\\\/www.legalserviceindia.com\\\/Legal-Articles\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/legalservicesind\",\"https:\\\/\\\/x.com\\\/legalserviceind\",\"https:\\\/\\\/www.youtube.com\\\/@LegalServiceIndia-lsi\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.legalserviceindia.com\\\/Legal-Articles\\\/#\\\/schema\\\/person\\\/96ae33c2330691e5b3ccd88cf127a305\",\"name\":\"ADVOCATE AJAY AMITABH SUMAN\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"\\\/\\\/www.gravatar.com\\\/avatar\\\/b894b0814afe1239db393e20da4b2e76?s=96&#038;r=g&#038;d=mm\",\"url\":\"\\\/\\\/www.gravatar.com\\\/avatar\\\/b894b0814afe1239db393e20da4b2e76?s=96&#038;r=g&#038;d=mm\",\"contentUrl\":\"\\\/\\\/www.gravatar.com\\\/avatar\\\/b894b0814afe1239db393e20da4b2e76?s=96&#038;r=g&#038;d=mm\",\"caption\":\"ADVOCATE AJAY AMITABH SUMAN\"},\"description\":\"Professional and Literary Profile Mr. Ajay Amitabh Suman, Advocate, is an alumnus of the Campus Law Centre, University of Delhi, with over 20 years of experience in IP litigation before the Delhi High Court. He currently serves as a Patent and Trademark Attorney at United &amp; United, a leading intellectual property law firm. Deeply committed to legal scholarship, he has authored more than 900 articles on intellectual property law, published on major platforms including Legal Service India, Bar &amp; Bench, Live Law, SCC Online Blog, Legal Desire, SpicyIP, among others. Beyond his legal practice, he is also an accomplished writer and poet, with over 1,500 literary works and more than 20 books published in Hindi and English. His journey reflects a unique blend of legal advocacy and creative expression, inspired by a passion for justice, knowledge, and reform.\",\"url\":\"https:\\\/\\\/www.legalserviceindia.com\\\/Legal-Articles\\\/author\\\/ajayamitabhsuman\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Milmet Oftho Industries v. Allergan Inc.: Supreme Court on Trans-Border Reputation &amp; Pharmaceutical Trademarks - Legal Service India - Articles","description":"Explore the Milmet v. Allergan Supreme Court ruling on transborder reputation, pharmaceutical trademarks, passing off, and prior user rights.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.legalserviceindia.com\/Legal-Articles\/milmet-oftho-industries-v-allergan-inc-supreme-court-on-trans-border-reputation-pharmaceutical-trademarks\/","og_locale":"en_US","og_type":"article","og_title":"Milmet Oftho Industries v. Allergan Inc.: Supreme Court on Trans-Border Reputation &amp; Pharmaceutical Trademarks","og_description":"Explore the Milmet v. Allergan Supreme Court ruling on transborder reputation, pharmaceutical trademarks, passing off, and prior user rights.","og_url":"https:\/\/www.legalserviceindia.com\/Legal-Articles\/milmet-oftho-industries-v-allergan-inc-supreme-court-on-trans-border-reputation-pharmaceutical-trademarks\/","og_site_name":"Legal Service India - Articles","article_publisher":"https:\/\/www.facebook.com\/legalservicesind","article_published_time":"2026-07-06T07:53:49+00:00","article_modified_time":"2026-07-06T07:55:58+00:00","author":"ADVOCATE AJAY AMITABH SUMAN","twitter_card":"summary_large_image","twitter_creator":"@legalserviceind","twitter_site":"@legalserviceind","twitter_misc":{"Written by":"ADVOCATE AJAY AMITABH SUMAN","Est. reading time":"11 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.legalserviceindia.com\/Legal-Articles\/milmet-oftho-industries-v-allergan-inc-supreme-court-on-trans-border-reputation-pharmaceutical-trademarks\/#article","isPartOf":{"@id":"https:\/\/www.legalserviceindia.com\/Legal-Articles\/milmet-oftho-industries-v-allergan-inc-supreme-court-on-trans-border-reputation-pharmaceutical-trademarks\/"},"author":{"name":"ADVOCATE AJAY AMITABH SUMAN","@id":"https:\/\/www.legalserviceindia.com\/Legal-Articles\/#\/schema\/person\/96ae33c2330691e5b3ccd88cf127a305"},"headline":"Milmet Oftho Industries v. Allergan Inc.: Supreme Court on Trans-Border Reputation &amp; Pharmaceutical Trademarks","datePublished":"2026-07-06T07:53:49+00:00","dateModified":"2026-07-06T07:55:58+00:00","mainEntityOfPage":{"@id":"https:\/\/www.legalserviceindia.com\/Legal-Articles\/milmet-oftho-industries-v-allergan-inc-supreme-court-on-trans-border-reputation-pharmaceutical-trademarks\/"},"wordCount":2432,"commentCount":0,"publisher":{"@id":"https:\/\/www.legalserviceindia.com\/Legal-Articles\/#organization"},"keywords":["Intellectual Property"],"articleSection":["Intellectual Property"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.legalserviceindia.com\/Legal-Articles\/milmet-oftho-industries-v-allergan-inc-supreme-court-on-trans-border-reputation-pharmaceutical-trademarks\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.legalserviceindia.com\/Legal-Articles\/milmet-oftho-industries-v-allergan-inc-supreme-court-on-trans-border-reputation-pharmaceutical-trademarks\/","url":"https:\/\/www.legalserviceindia.com\/Legal-Articles\/milmet-oftho-industries-v-allergan-inc-supreme-court-on-trans-border-reputation-pharmaceutical-trademarks\/","name":"Milmet Oftho Industries v. Allergan Inc.: Supreme Court on Trans-Border Reputation &amp; Pharmaceutical Trademarks - Legal Service India - Articles","isPartOf":{"@id":"https:\/\/www.legalserviceindia.com\/Legal-Articles\/#website"},"datePublished":"2026-07-06T07:53:49+00:00","dateModified":"2026-07-06T07:55:58+00:00","description":"Explore the Milmet v. Allergan Supreme Court ruling on transborder reputation, pharmaceutical trademarks, passing off, and prior user rights.","breadcrumb":{"@id":"https:\/\/www.legalserviceindia.com\/Legal-Articles\/milmet-oftho-industries-v-allergan-inc-supreme-court-on-trans-border-reputation-pharmaceutical-trademarks\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.legalserviceindia.com\/Legal-Articles\/milmet-oftho-industries-v-allergan-inc-supreme-court-on-trans-border-reputation-pharmaceutical-trademarks\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.legalserviceindia.com\/Legal-Articles\/milmet-oftho-industries-v-allergan-inc-supreme-court-on-trans-border-reputation-pharmaceutical-trademarks\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.legalserviceindia.com\/Legal-Articles\/"},{"@type":"ListItem","position":2,"name":"Intellectual Property > Milmet Oftho Industries v. Allergan Inc.: Supreme Court on Trans-Border Reputation & Pharmaceutical Trademarks"}]},{"@type":"WebSite","@id":"https:\/\/www.legalserviceindia.com\/Legal-Articles\/#website","url":"https:\/\/www.legalserviceindia.com\/Legal-Articles\/","name":"Legal Service India - Law Articles","description":"Legal Service India - Law Article Directory is the oldest in India since 2000, with thousands of article written by lawyers, law Students and Scholars on all branches of law","publisher":{"@id":"https:\/\/www.legalserviceindia.com\/Legal-Articles\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.legalserviceindia.com\/Legal-Articles\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.legalserviceindia.com\/Legal-Articles\/#organization","name":"Legal Service India","url":"https:\/\/www.legalserviceindia.com\/Legal-Articles\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.legalserviceindia.com\/Legal-Articles\/#\/schema\/logo\/image\/","url":"https:\/\/www.legalserviceindia.com\/Legal-Articles\/wp-content\/uploads\/2025\/06\/logo-circle-1.png","contentUrl":"https:\/\/www.legalserviceindia.com\/Legal-Articles\/wp-content\/uploads\/2025\/06\/logo-circle-1.png","width":105,"height":95,"caption":"Legal Service India"},"image":{"@id":"https:\/\/www.legalserviceindia.com\/Legal-Articles\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/legalservicesind","https:\/\/x.com\/legalserviceind","https:\/\/www.youtube.com\/@LegalServiceIndia-lsi"]},{"@type":"Person","@id":"https:\/\/www.legalserviceindia.com\/Legal-Articles\/#\/schema\/person\/96ae33c2330691e5b3ccd88cf127a305","name":"ADVOCATE AJAY AMITABH SUMAN","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"\/\/www.gravatar.com\/avatar\/b894b0814afe1239db393e20da4b2e76?s=96&#038;r=g&#038;d=mm","url":"\/\/www.gravatar.com\/avatar\/b894b0814afe1239db393e20da4b2e76?s=96&#038;r=g&#038;d=mm","contentUrl":"\/\/www.gravatar.com\/avatar\/b894b0814afe1239db393e20da4b2e76?s=96&#038;r=g&#038;d=mm","caption":"ADVOCATE AJAY AMITABH SUMAN"},"description":"Professional and Literary Profile Mr. Ajay Amitabh Suman, Advocate, is an alumnus of the Campus Law Centre, University of Delhi, with over 20 years of experience in IP litigation before the Delhi High Court. He currently serves as a Patent and Trademark Attorney at United &amp; United, a leading intellectual property law firm. Deeply committed to legal scholarship, he has authored more than 900 articles on intellectual property law, published on major platforms including Legal Service India, Bar &amp; Bench, Live Law, SCC Online Blog, Legal Desire, SpicyIP, among others. Beyond his legal practice, he is also an accomplished writer and poet, with over 1,500 literary works and more than 20 books published in Hindi and English. His journey reflects a unique blend of legal advocacy and creative expression, inspired by a passion for justice, knowledge, and reform.","url":"https:\/\/www.legalserviceindia.com\/Legal-Articles\/author\/ajayamitabhsuman\/"}]}},"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.legalserviceindia.com\/Legal-Articles\/wp-json\/wp\/v2\/posts\/27024","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.legalserviceindia.com\/Legal-Articles\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.legalserviceindia.com\/Legal-Articles\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.legalserviceindia.com\/Legal-Articles\/wp-json\/wp\/v2\/users\/56"}],"replies":[{"embeddable":true,"href":"https:\/\/www.legalserviceindia.com\/Legal-Articles\/wp-json\/wp\/v2\/comments?post=27024"}],"version-history":[{"count":2,"href":"https:\/\/www.legalserviceindia.com\/Legal-Articles\/wp-json\/wp\/v2\/posts\/27024\/revisions"}],"predecessor-version":[{"id":27421,"href":"https:\/\/www.legalserviceindia.com\/Legal-Articles\/wp-json\/wp\/v2\/posts\/27024\/revisions\/27421"}],"wp:attachment":[{"href":"https:\/\/www.legalserviceindia.com\/Legal-Articles\/wp-json\/wp\/v2\/media?parent=27024"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.legalserviceindia.com\/Legal-Articles\/wp-json\/wp\/v2\/categories?post=27024"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.legalserviceindia.com\/Legal-Articles\/wp-json\/wp\/v2\/tags?post=27024"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}